CMPX Compass Therapeutics, Inc. - Common Stock
$2,49
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 6, 2026
52W-Spanne
$2–$7
17% of range
Analystenbewertung
BUY
21 analysts
Kursziel
$9
+259% upside
P/E (TTM)
—
ROE
-45.9%
Nettogewinnmarge
—
CMPX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$2.48
Marktkapitalisierung
$443M
P/E (TTM)
—
EPS (TTM)
—
Umsatz (TTM)
$0
Dividendenrendite
—
ROE
-45.9%
Verschuldungsgrad
—
52W-Spanne
$2 – $7
CMPX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$0
2023-12-31
→
2025-12-31
EPS
—
Freier Cashflow
$-49M
2020-12-31
→
2025-12-31
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
CMPX
Peer-Median
P/B (K/B)
2.3
4.8
Price / FCF (Kurs / FCF)
-9.0
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
CMPX
Peer-Median
ROA
-36.9%
-41.1%
ROE
-45.9%
-52.6%
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
CMPX
Peer-Median
Current Ratio (Liquiditätsgrad)
15.0
7.7
Quick Ratio
15.0
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
CMPX
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
CMPX
Peer-Median
CMPX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
21 Analysten
- Starker Kauf 9 42,9%
- Kauf 10 47,6%
- Halten 2 9,5%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
12 Analysten · 2026-08-13
Median
$7.00
Mittelwert
$8.92
← Unter allen Zielen
$2.48
Tief
$5.00
Hoch
$24.00
Median-Ziel
$7.00
+181,7%
Mittelwert-Ziel
$8.92
+258,8%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.00%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.13 | $-0.11 | -0.02% |
| 31. März 2026 | $-0.10 | $-0.10 | 0.00% |
| 31. Dezember 2025 | $-0.09 | $-0.09 | 0.00% |
| 30. September 2025 | $-0.08 | $-0.14 | 0.06% |
| 30. Juni 2025 | $-0.14 | $-0.12 | -0.02% |
| 31. März 2025 | $-0.12 | $-0.11 | -0.01% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| CMPX | $958M | — | — | — | -45.9% | — |
| PBYI | $300M | 9.8 | -0.91% | 13.6% | 26.5% | — |
| RZLT | $388M | -4.6 | — | — | -56.9% | — |
| BNTC | $307M | -11.1 | — | — | -43.8% | — |
| EDIT | $201M | -1.1 | 25.4% | -395.0% | -688.8% | — |
| PROK | — | — | 1075.0% | -7725.2% | 6.9% | — |
| FENC | $263M | -22.6 | -6.1% | -21.8% | -69.6% | — |
| LXEO | $725M | -5.3 | — | — | -51.9% | — |
| CAPR | $1.66B | -12.8 | -11.6% | — | -51.1% | — |
| FHTX | $306M | -4.6 | 36.8% | -240.3% | 80.2% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $0 | $850.0K | $0 | |
| R&D Expense | $56M | $42M | $38M | |
| SG&A Expense | $17M | $15M | $12M | |
| Operating Expenses | $73M | $57M | $50M | |
| Operating Income | $-73M | $-57M | $-50M | |
| Interest Income | $6M | $7M | $8M | |
| Other Non-op | $6M | $7M | $8M | |
| Pretax Income | · | · | $-42M | |
| Income Tax | $0 | $0 | $0 | |
| Net Income | $-66M | $-49M | $-42M | |
| EPS (Basic) | $-0.42 | $-0.36 | $-0.33 | |
| Shares (Basic) | 157,695,000 | 137,384,000 | 127,027,000 | |
| Shares (Diluted) | · | 137,400,000 | · | |
| EBITDA | $-73M | $-57M | $-50M |
Bilanz 20
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $31M | $43M | $24M | |
| Short-term Investments | $178M | $83M | $128M | |
| Prepaid Expense | $913.0K | $6M | $1M | |
| Current Assets | $210M | $133M | $154M | |
| PP&E (Net) | $102.0K | $353.0K | $898.0K | |
| PP&E (Gross) | $7M | $7M | $7M | |
| Accum. Depreciation | $7M | $6M | $6M | |
| Other Non-current Assets | · | $568.0K | $320.0K | |
| Total Assets | $220M | $140M | $157M | |
| Accounts Payable | $2M | $2M | $4M | |
| Accrued Liabilities | $11M | $6M | $3M | |
| Current Liabilities | $14M | $9M | $8M | |
| Capital Leases | $9M | $6M | $536.0K | |
| Total Liabilities | $23M | $15M | $8M | |
| Common Stock | $18.0K | $14.0K | $13.0K | |
| Retained Earnings | $-431M | $-365M | $-315M | |
| AOCI | $280.0K | $210.0K | $37.0K | |
| Stockholders' Equity | $197M | $125M | $149M | |
| Liabilities + Equity | $220M | $140M | $157M | |
| Shares Outstanding | 178,324,000 | 137,820,000 | 127,668,000 |
Cashflow 10
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $276.0K | $589.0K | $699.0K | |
| Stock-based Comp | $8M | $9M | $6M | |
| Operating Cash Flow | $-49M | $-45M | $-41M | |
| CapEx | $25.0K | $44.0K | $30.0K | |
| Investing Cash Flow | $-93M | $47M | $27M | |
| Stock Issued | $138M | $18M | $3M | |
| Net Stock Activity | $138M | $18M | $3M | |
| Financing Cash Flow | $130M | $17M | $3M | |
| Net Change in Cash | $-13M | $19M | $-11M | |
| Free Cash Flow | $-49M | $-45M | $-41M |
Rentabilität 6
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | · | -6661.8% | · | |
| Net Margin | · | -5808.8% | · | |
| EBITDA Margin | · | -6661.8% | · | |
| ROA | -36.9% | -33.2% | -23.8% | |
| ROE | -45.9% | -37.5% | -27.5% | |
| ROIC | · | · | -33.9% |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 15.0 | 15.0 | 19.7 | |
| Quick Ratio | 15.0 | 14.3 | 19.5 |
Effizienz 1
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · |
Bewertung (TTM) 8
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $0 | $850.0K | $0 | |
| Net Income TTM | $-66M | $-49M | $-42M | |
| Market Cap | $958M | $200M | $199M | |
| P/S | · | 235.1 | · | |
| P/B | 4.9 | 1.6 | 1.3 | |
| P / Tangible Book | 4.9 | 1.6 | 1.3 | |
| P / Cash Flow | -19.5 | -4.5 | -4.9 | |
| P / FCF | -19.5 | -4.5 | -4.9 |
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | $0 | $0 | · | $0 | $0 | $850.0K | · | $0 | $0 | $0 | |
| R&D Expense | · | $13M | $14M | $13M | $16M | $13M | $13M | $9M | $11M | $10M | · | · | · | |
| SG&A Expense | $7M | $7M | $4M | $3M | $5M | $5M | $4M | $4M | $5M | $3M | $3M | $3M | $3M | |
| Operating Expenses | $27M | $20M | $18M | $16M | $21M | $18M | $17M | $12M | $16M | $13M | $15M | $12M | $13M | |
| Operating Income | $-27M | $-20M | $-18M | $-16M | $-21M | $-18M | $-17M | $-12M | $-15M | $-13M | $-15M | $-12M | $-13M | |
| Interest Income | · | · | · | · | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-op | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Pretax Income | · | · | · | · | · | $-17M | · | · | $-13M | $-11M | · | $-10M | $-11M | |
| Income Tax | · | · | · | · | · | $0 | · | · | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-25M | $-18M | $-16M | $-14M | $-20M | $-17M | $-15M | $-10M | $-13M | $-11M | $-13M | $-10M | $-11M | |
| EPS (Basic) | $-0.13 | $-0.10 | $-0.08 | $-0.08 | $-0.14 | $-0.12 | $-0.10 | $-0.08 | $-0.10 | $-0.08 | $-0.10 | $-0.08 | $-0.09 | |
| Shares (Basic) | 186,798,000 | 186,400,000 | -287,605,000 | 168,782,000 | 138,282,000 | 138,236,000 | -274,402,000 | 137,589,000 | 137,589,000 | 136,608,000 | -253,501,000 | 127,424,000 | 126,729,000 | |
| Shares (Diluted) | · | · | · | · | · | 138,200,000 | 100,000 | 137,600,000 | · | · | · | · | · | |
| EBITDA | $-27M | $-20M | · | $-16M | $-21M | $-18M | · | $-12M | $-15M | $-13M | · | $-12M | $-13M |
Bilanz 20
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $35M | $55M | $31M | $46M | $23M | $41M | $43M | $37M | $19M | $24M | $24M | $30M | $19M | |
| Short-term Investments | $144M | $140M | $178M | $174M | $78M | $72M | $83M | $99M | $127M | $133M | $128M | $133M | $149M | |
| Prepaid Expense | $1M | $1M | $913.0K | $1M | $5M | $12M | $6M | $6M | $7M | $2M | $1M | $3M | $7M | |
| Current Assets | $181M | $196M | $210M | $221M | $106M | $124M | $133M | $141M | $154M | $159M | $154M | $167M | $175M | |
| PP&E (Net) | $324.0K | $169.0K | $102.0K | $119.0K | $131.0K | $231.0K | $353.0K | $493.0K | $592.0K | $744.0K | $898.0K | $1M | $1M | |
| PP&E (Gross) | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | |
| Accum. Depreciation | $7M | $7M | $7M | $7M | $7M | $7M | $6M | $7M | $7M | $6M | $6M | $6M | $6M | |
| Other Non-current Assets | · | · | · | · | · | · | · | $568.0K | $320.0K | $320.0K | $320.0K | $320.0K | $320.0K | |
| Total Assets | $190M | $205M | $220M | $231M | $117M | $131M | $140M | $149M | $156M | $161M | $157M | $170M | $179M | |
| Accounts Payable | $3M | $906.0K | $2M | $3M | $3M | $2M | $2M | $960.0K | $1M | $854.0K | $4M | $2M | $724.0K | |
| Accrued Liabilities | $12M | $8M | $11M | $9M | $11M | $13M | $6M | $3M | $7M | $2M | $3M | $6M | $8M | |
| Current Liabilities | $16M | $10M | $14M | $12M | $14M | $15M | $9M | $4M | $10M | $4M | $8M | $9M | $10M | |
| Capital Leases | $8M | $8M | $9M | $9M | $10M | $6M | $6M | $6M | $0 | $189.0K | $536.0K | $869.0K | $1M | |
| Total Liabilities | $24M | $19M | $23M | $22M | $23M | $21M | $15M | $11M | $10M | $4M | $8M | $10M | $11M | |
| Common Stock | $18.0K | $18.0K | $18.0K | $53.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $13.0K | $13.0K | $13.0K | |
| Retained Earnings | $-475M | $-449M | $-431M | $-415M | $-401M | $-381M | $-365M | $-350M | $-339M | $-326M | $-315M | $-302M | $-292M | |
| AOCI | $-251.0K | $-159.0K | $280.0K | $274.0K | $208.0K | $190.0K | $210.0K | $486.0K | $-91.0K | $-90.0K | $37.0K | $-430.0K | $-507.0K | |
| Stockholders' Equity | $166M | $186M | $197M | $210M | $93M | $110M | $125M | $138M | $146M | $157M | $149M | $160M | $168M | |
| Liabilities + Equity | $190M | $205M | $220M | $231M | $117M | $131M | $140M | $149M | $156M | $161M | $157M | $170M | $179M | |
| Shares Outstanding | 180,088,000 | 180,088,000 | 178,324,000 | 177,572,000 | 138,282,000 | 138,282,000 | 137,820,000 | 137,589,000 | 137,589,000 | 137,589,000 | 127,668,000 | 127,445,000 | 127,388,000 |
Cashflow 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $21.0K | $15.0K | $17.0K | $19.0K | $100.0K | $140.0K | $140.0K | $143.0K | $152.0K | $154.0K | $161.0K | $164.0K | $180.0K | |
| Stock-based Comp | $5M | $5M | $2M | $1M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Cash Flow | $-15M | $-17M | $-13M | $-11M | $-12M | $-13M | $-9M | $-11M | $-11M | $-14M | $-12M | $-6M | $-10M | |
| CapEx | $176.0K | $82.0K | $0 | $7.0K | $0 | $18.0K | $0 | $44.0K | $0 | $0 | $9.0K | $10.0K | $11.0K | |
| Investing Cash Flow | $-5M | $38M | $-3M | $-95M | $-6M | $12M | $15M | $29M | $6M | $-4M | $6M | $17M | $-667.0K | |
| Stock Issued | · | · | $0 | $138M | $0 | $0 | $0 | $0 | $0 | $18M | $0 | $0 | $3M | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $18M | · | · | · | |
| Financing Cash Flow | $0 | $3M | $1M | $129M | $0 | $-815.0K | $-94.0K | $-2.0K | $1.0K | $17M | $-158.0K | $21.0K | $3M | |
| Net Change in Cash | $-20M | $25M | $-16M | $23M | $-18M | $-2M | $6M | $18M | $-4M | $-554.0K | $-6M | $11M | $-8M | |
| Free Cash Flow | · | $-17M | · | · | · | $-13M | · | · | · | · | · | · | · |
Rentabilität 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | -1770.0% | · | · | · | · | |
| Net Margin | · | · | · | · | · | · | · | · | -1538.3% | · | · | · | · | |
| Pretax Margin | · | · | · | · | · | · | · | · | -1538.3% | · | · | · | · | |
| EBITDA Margin | · | · | · | · | · | · | · | · | -1770.0% | · | · | · | · | |
| ROA | -16.4% | -10.9% | · | -7.5% | -14.6% | -11.4% | · | -6.6% | -7.8% | -6.2% | · | -6.7% | -7.1% | |
| ROE | -19.4% | -12.3% | · | -8.2% | -16.6% | -12.4% | · | -7.0% | -8.3% | -6.5% | · | -7.2% | -7.6% | |
| ROIC | · | · | · | · | · | -16.3% | · | · | -10.3% | -8.1% | · | -7.4% | -7.9% |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.2 | 19.0 | · | 17.8 | 7.7 | 8.3 | · | 31.8 | 16.2 | 40.7 | · | 18.3 | 18.1 | |
| Quick Ratio | 11.2 | 18.9 | · | 17.7 | 7.3 | 7.6 | · | 30.5 | 15.4 | 40.1 | · | 17.9 | 17.4 |
Effizienz 1
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.0 | · | · | 0.0 | 0.0 | · | · | · | · |
Bewertung (TTM) 6
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-78M | $-69M | · | $-61M | $-60M | $-51M | · | $-44M | $-45M | $-40M | · | $-41M | $-40M | |
| Market Cap | $394M | $953M | · | $622M | $360M | $263M | · | $253M | $138M | $272M | · | $251M | $405M | |
| P/B | 2.4 | 5.1 | · | 3.0 | 3.9 | 2.4 | · | 1.8 | 0.9 | 1.7 | · | 1.6 | 2.4 | |
| P / Tangible Book | 2.4 | 5.1 | · | 3.0 | 3.9 | 2.4 | · | 1.8 | 0.9 | 1.7 | · | 1.6 | 2.4 | |
| P / Cash Flow | · | -55.2 | · | · | · | -19.9 | · | · | · | -19.6 | · | · | · | |
| P / FCF | · | -54.9 | · | · | · | -19.9 | · | · | · | · | · | · | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $0 | $850.0K | $0 | — | — |
| Betriebsgewinnmarge % | — | -6661.8% | — | — | — |
| Nettoergebnis | $-66M | $-49M | $-42M | $-39M | $-82M |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | — | — | — | — | 0.0 |
| Liquiditätsgrad | 15.0 | 15.0 | 19.7 | 12.0 | 13.8 |
| Quick Ratio | 15.0 | 14.3 | 19.5 | 11.5 | 13.6 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-49M | $-45M | $-41M | $-34M | $-21M |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 227 Einreicher · $346.6M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 72 (+23 vs. Vorquartal) | 42 (+22 vs. Vorquartal) | 76 (+11 vs. Vorquartal) | 45 (-2 vs. Vorquartal) | -5.0M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | $39.399.813 | 17.990.782 | 11,37% | Aktien |
| VANGUARD GROUP INC | $37.441.444 | 6.972.336 | 10,80% | Aktien |
| ORBIMED ADVISORS LLC | $33.331.787 | 15.219.994 | 9,62% | Aktien |
| MONTANOVA CAPITAL, LLC | $30.881.538 | 14.101.159 | 8,91% | Aktien |
| STATE STREET CORP | $21.798.500 | 9.953.653 | 6,29% | Aktien |
| ENAVATE SCIENCES GP, LLC | $17.056.049 | 7.788.150 | 4,92% | Aktien |
| Vivo Capital, LLC | $16.987.961 | 7.757.060 | 4,90% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $13.400.133 | 6.118.782 | 3,87% | Aktien |
| Palo Alto Investors LP | $12.771.670 | 5.831.813 | 3,68% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $10.322.011 | 4.713.247 | 2,98% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $8.258.560 | 3.771.032 | 2,38% | Aktien |
| Qube Research & Technologies Ltd | $8.075.601 | 3.687.489 | 2,33% | Aktien |
| Blue Owl Capital Holdings LP | $7.936.726 | 3.624.076 | 2,29% | Aktien |
| Rock Springs Capital Management LP | $7.719.595 | 3.524.929 | 2,23% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $7.167.845 | 3.271.990 | 2,07% | Aktien |
| GOLDMAN SACHS GROUP INC | $5.881.777 | 2.685.743 | 1,70% | Aktien |
| Birchview Capital, LP | $3.668.250 | 1.675.000 | 1,06% | Aktien |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | $3.066.000 | 1.400.000 | 0,88% | Aktien |
| Fisher Asset Management, LLC | $3.048.238 | 1.391.890 | 0,88% | Aktien |
| ROYCE & ASSOCIATES LP | $2.927.548 | 1.336.780 | 0,84% | Aktien |
| FMR LLC | $2.654.709 | 1.212.196 | 0,77% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $2.598.435 | 1.186.500 | 0,75% | Aktien |
| Atle Fund Management AB | $2.296.418 | 1.048.593 | 0,66% | Aktien |
| Squarepoint Ops LLC | $2.206.440 | 1.007.507 | 0,64% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $2.192.054 | 1.000.938 | 0,63% | Aktien |
| Blackstone Inc. | $1.970.860 | 899.936 | 0,57% | Aktien |
| FIRST TRUST ADVISORS LP | $1.767.338 | 807.004 | 0,51% | Aktien |
| KVP Capital Advisors, LP | $1.688.490 | 771.000 | 0,49% | Aktien |
| UBS Group AG | $1.560.951 | 712.763 | 0,45% | Aktien |
| CITIGROUP INC | $1.546.887 | 706.341 | 0,45% | Aktien |
| Burkehill Global Management, LP | $1.533.000 | 700.000 | 0,44% | Aktien |
| JPMORGAN CHASE & CO | $1.505.377 | 696.934 | 0,43% | Aktien |
| Point72 Asset Management, L.P. | $1.503.604 | 686.577 | 0,43% | Aktien |
| ACUTA CAPITAL PARTNERS, LLC | $1.303.516 | 595.213 | 0,38% | Aktien |
| CM Management, LLC | $1.204.500 | 550.000 | 0,35% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $1.147.072 | 523.777 | 0,33% | Aktien |
| MORGAN STANLEY | $1.088.441 | 497.005 | 0,31% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $1.045.092 | 477.211 | 0,30% | Aktien |
| BANK OF AMERICA CORP /DE/ | $994.089 | 453.922 | 0,29% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $856.345 | 161.880 | 0,25% | Aktien |
| Artia Global Partners LP | $839.208 | 383.200 | 0,24% | Aktien |
| ArrowMark Colorado Holdings LLC | $798.785 | 364.742 | 0,23% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $701.483 | 320.312 | 0,20% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $675.166 | 308.295 | 0,19% | Aktien |
| ALGERT GLOBAL LLC | $674.761 | 308.110 | 0,19% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $663.874 | 303.139 | 0,19% | Aktien |
| NATIXIS | $651.996 | 297.715 | 0,19% | Aktien |
| Exome Asset Management LLC | $604.801 | 276.165 | 0,17% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $594.152 | 112.316 | 0,17% | Aktien |
| Caption Management, LLC | $577.234 | 263.577 | 0,17% | Aktien |
| TEMA ETFS LLC | $537.945 | 100.176 | 0,16% | Aktien |
| Seven Fleet Capital Management LP | $510.415 | 233.066 | 0,15% | Aktien |
| DV EQUITIES, LLC | $510.415 | 233.066 | 0,15% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $486.572 | 222.179 | 0,14% | Aktien |
| XTX Topco Ltd | $476.292 | 217.485 | 0,14% | Aktien |
| Orion Porfolio Solutions, LLC | $468.360 | 213.863 | 0,14% | Aktien |
| Optimize Financial Inc | $425.522 | 80.439 | 0,12% | Aktien |
| Rafferty Asset Management, LLC | $416.376 | 190.126 | 0,12% | Aktien |
| ALPS ADVISORS INC | $400.282 | 182.777 | 0,12% | Aktien |
| Mariner, LLC | $378.432 | 172.821 | 0,11% | Aktien |
| Swiss National Bank | $376.023 | 171.700 | 0,11% | Aktien |
| JANE STREET GROUP, LLC | $372.300 | 170.000 | 0,11% | Kaufoption |
| Virtus Investment Advisers, LLC | $352.986 | 161.181 | 0,10% | Aktien |
| CANADA PENSION PLAN INVESTMENT BOARD | $352.371 | 160.900 | 0,10% | Aktien |
| RHUMBLINE ADVISERS | $346.984 | 158.444 | 0,10% | Aktien |
| JANUS HENDERSON GROUP PLC | $293.846 | 55.600 | 0,08% | Aktien |
| IEQ CAPITAL, LLC | $269.256 | 122.948 | 0,08% | Aktien |
| ADAR1 Capital Management, LLC | $267.469 | 122.132 | 0,08% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $249.165 | 113.774 | 0,07% | Aktien |
| Bank of New York Mellon Corp | $242.878 | 110.903 | 0,07% | Aktien |
| WELLS FARGO & COMPANY/MN | $240.447 | 109.793 | 0,07% | Aktien |
| Quadrature Capital Ltd | $237.068 | 108.250 | 0,07% | Aktien |
| MERCER GLOBAL ADVISORS INC /ADV | $233.388 | 106.570 | 0,07% | Aktien |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $230.198 | 105.113 | 0,07% | Aktien |
| PROFUND ADVISORS LLC | $208.508 | 95.209 | 0,06% | Aktien |
| Schonfeld Strategic Advisors LLC | $201.975 | 92.227 | 0,06% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $197.196 | 90.044 | 0,06% | Aktien |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $194.711 | 83.567 | 0,06% | Aktien |
| Jain Global LLC | $193.381 | 88.302 | 0,06% | Aktien |
| SmartHarvest Portfolios, LLC | $189.453 | 86.508 | 0,05% | Aktien |
| GROUP ONE TRADING LLC | $178.610 | 81.557 | 0,05% | Aktien |
| BlackRock, Inc. | $178.213 | 81.376 | 0,05% | Aktien |
| CITADEL ADVISORS LLC | $177.390 | 81.000 | 0,05% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $163.569 | 74.689 | 0,05% | Aktien |
| CITADEL ADVISORS LLC | $161.622 | 73.800 | 0,05% | Kaufoption |
| MetLife Investment Management, LLC | $156.412 | 71.421 | 0,05% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $149.395 | 68.217 | 0,04% | Aktien |
| ExodusPoint Capital Management, LP | $147.777 | 67.478 | 0,04% | Aktien |
| CITADEL ADVISORS LLC | $143.445 | 65.500 | 0,04% | Verkaufsoption |
| D. E. Shaw & Co., Inc. | $141.612 | 64.663 | 0,04% | Aktien |
| Vanguard Global Advisers, LLC | $133.936 | 61.158 | 0,04% | Aktien |
| Wealthcare Advisory Partners LLC | $133.507 | 60.962 | 0,04% | Aktien |
| Quantbot Technologies LP | $133.209 | 60.826 | 0,04% | Aktien |
| JANE STREET GROUP, LLC | $131.301 | 59.955 | 0,04% | Aktien |
| SIMPLEX TRADING, LLC | $126.560 | 57.790 | 0,04% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $123.078 | 56.200 | 0,04% | Verkaufsoption |
| Focus Partners Wealth | $116.335 | 53.121 | 0,03% | Aktien |
| Invesco Ltd. | $114.701 | 52.375 | 0,03% | Aktien |
| Sequoia Financial Advisors, LLC | $98.507 | 44.980 | 0,03% | Aktien |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $96.172 | 43.914 | 0,03% | Aktien |
Unternehmensinsider 18 Insider · 8 Führungskräfte · 12 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Thomas J. Schuetz | CHIEF EXECUTIVE OFFICER | 8. Februar 2026 F | 6.603.336 | 0 | 0 | $0 |
| Vered Bisker-Leib | CHIEF EXECUTIVE OFFICER | 8. Februar 2024 F | 3.124.426 | 0 | 0 | $0 |
| Barry Shin | CFO | 2. Januar 2026 A | 525.000 | 0 | 0 | $0 |
| Jonathan Anderman | General Counsel | 29. April 2026 P | 196.000 | 1 | 0 | $47.250 |
| Neil Lerner | Chief Accounting Officer | 29. April 2026 P | 397.500 | 1 | 0 | $28.350 |
| Arjun Prasad | Chief Commercial Officer | 2. Januar 2026 A | — | 0 | 0 | $0 |
| Cynthia Sirard | Chief Medical Officer | 2. Januar 2026 A | — | 0 | 0 | $0 |
| Susan Kalled | Chief Scientific Officer | 18. Februar 2022 A | — | 0 | 0 | $0 |
| James P Boylan | Direktor | 2. Januar 2026 A | — | 0 | 0 | $0 |
| Philip Ferneau | Direktor | 2. Januar 2026 A | 400.280 | 0 | 0 | $0 |
| Ellen Chiniara | Direktor | 2. Januar 2026 A | — | 0 | 0 | $0 |
| GORDON CARL L | Direktor | 2. Januar 2026 A | 0 | 0 | 0 | $0 |
| Mary Ann Gray | Direktor | 2. Januar 2026 A | — | 0 | 0 | $0 |
| Richard S Lindahl | Direktor | 2. Januar 2026 A | — | 0 | 0 | $0 |
| David M Wurzer | Direktor | 8. Februar 2023 A | — | 0 | 0 | $0 |
| Brett Kaplan | Direktor | 18. Februar 2022 A | — | 0 | 0 | $0 |
| Stephen P Squinto | Direktor | 18. Februar 2022 A | — | 0 | 0 | $0 |
| Julie Sunderland | Direktor | 19. Juni 2020 P | 2.502.025 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 5 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Commander Aggregator, LP, Enavate Sciences, LP, Enavate Sciences GP, LLC, Enavate Sciences Holdings, LLC | 18. August 2025 | 4,50% | Änderung | — | SEC |
| ORBIMED ADVISORS LLC, ORBIMED CAPITAL GP V LLC ×7 Einreichungen | 15. August 2025 | 8,90% | Änderung | — | SEC |
| Nicht offengelegter meldender Beteiligter | 14. November 2022 | — | Erste Einreichung | — | SEC |
| Philip Ferneau, Vox Health Fund, L.P., Borealis Capital Partners IV, LLC, Borealis Granite Fund, L.P., Borealis Capital Partners III, LLC | 26. Juni 2020 | — | Erste Einreichung | — | SEC |
| Thomas J. Schuetz | 26. Juni 2020 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 30 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 0,27% | 185.633 NS | 31. Mai 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,25% | 53.489 NS | 30. April 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,07% | 441.490 NS | 30. April 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,07% | 210.822 NS | 30. April 2026 | N-PORT |
| IWC · iShares Trust | 0,06% | 448.663 SH | 8. August 2026 | Täglich |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,04% | 261.767 NS | 30. April 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 114.090 SH | 8. August 2026 | Täglich |
| IWN · iShares Trust | 0,02% | 1.200.652 SH | 8. August 2026 | Täglich |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,02% | 41.165 NS | 30. April 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,01% | 46.574 NS | 31. Mai 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 754.118 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,01% | 3.388.508 SH | 8. August 2026 | Täglich |
| ITWO · ProShares Trust | 0,01% | 6.071 NS | 31. Mai 2026 | N-PORT |
| RSSL · Global X Funds | 0,01% | 55.815 NS | 30. April 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 4.749 NS | 31. Mai 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 4.800 NS | 31. Mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,00% | 51.153 NS | 30. April 2026 | N-PORT |
| WSML · iShares Trust | 0,00% | 6.789 SH | 8. August 2026 | Täglich |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 64.580 NS | 31. Mai 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 4.596 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 121 NS | 31. Mai 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 244.958 SH | 8. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,00% | 28.557 NS | 30. April 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 33.872 SH | 8. August 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 1.793.659 SH | 8. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 4.190.754 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 11.073 SH | 8. August 2026 | Täglich |
| DFAU · Dimensional ETF Trust | 0,00% | 2.437 NS | 30. April 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 7.766 NS | 30. April 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,00% | 257.838 SH | 8. August 2026 | Täglich |